More forecasts: Atlanta 30 day forecast
Goldman-Backed San Carlos Biotech Attovia Chases $731.5 Million Nasdaq Payday
Aug 04, 2026
San Carlos biotech Attovia is seeking $289 million in an upsized IPO targeting a $731.5 million valuation. Its pipeline is still years from potential commercialization.












